Skip to main content
. 2020 Jan 9;105(4):e1847–e1861. doi: 10.1210/clinem/dgz310

Table 3.

Statistical analysis of annualized height velocity

ETD (95% CI); cm/y
Wk 26 Wk 52
Somapacitan 0.16 mg/kg/wk—daily GH 1.7 (–0.2 to 3.6) 1.8 (0.5 to 3.1)
Somapacitan 0.08 mg/kg/wk—daily GH –0.6 (–2.4 to 1.3) –0.2 (–1.5 to 1.1)
Somapacitan 0.04 mg/kg/wk—daily GH –3.7 (–5.6 to –1.8) –2.4 (–3.7 to –1.1)

Abbreviations: ETD, estimated treatment difference; GH, growth hormone; wk, week; y, year.